Gagnon Robert E. — SEC Form 4 filings
SEC reporting owner CIK 1504983. 22 Form 4 filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2024-01-10 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 17 legs across 14 filings — 64,825 shares, $435,482 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 28,000 shares @ $4.54 ($127,212) in Opus Genetics, Inc., filed 2026-09-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Verastem, Inc. (VSTM) | Director | 12 | — | 14 legs · 21,200 sh · $244,670 | 4 |
| Opus Genetics, Inc. (IRD) | Chief Financial Officer | 5 | — | 3 legs · 43,625 sh · $190,812 | 3 |
| Bone Biologics Corp (BBLG) | Director | 3 | — | — | 4 |
| HARVARD BIOSCIENCE INC (HBIO) | Director | 2 | — | — | 2 |
Form 4 filings — Gagnon Robert E.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 28,000 @ $4.54 | EDGAR |
| 2026-07-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 7,783 @ $2.95 | EDGAR |
| 2026-06-11 | 4 | HARVARD BIOSCIENCE INC (HBIO) | Grant/award (A): 16,556 @ $0 | EDGAR |
| 2026-04-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 7,842 @ $5.18 | EDGAR |
| 2026-01-26 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2025-12-18 | 4 | Verastem, Inc. (VSTM) | Sale (S): 283 @ $9.14 | EDGAR |
| 2025-09-18 | 4 | Verastem, Inc. (VSTM) | Sale (S): 281 @ $9.99 | EDGAR |
| 2025-09-11 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 200,000 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | HARVARD BIOSCIENCE INC (HBIO) | Grant/award (A): 110,000 @ $0 | EDGAR |
| 2025-06-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 284 @ $5.65 | EDGAR |
| 2025-06-06 | 4 | Bone Biologics Corp (BBLG) | Grant/award (A): 62,894 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Verastem, Inc. (VSTM) | Grant/award (A): 8,333 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-03-19 | 4 | Verastem, Inc. (VSTM) | Sale (S): 284 @ $6.95 | EDGAR |
| 2024-12-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 285 @ $4.54 · Sale (S): 130 @ $4.37 | EDGAR |
| 2024-09-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 131 @ $2.79 | EDGAR |
| 2024-09-19 | 4 | Bone Biologics Corp (BBLG) | Grant/award (A): 30,713 (derivative) @ $0 | EDGAR |
| 2024-09-18 | 4 | Verastem, Inc. (VSTM) | Sale (S): 287 @ $2.80 | EDGAR |
| 2024-06-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 283 @ $3.49 · Grant/award (A): 8,333 @ $0 · Sale (S): 131 @ $3.21 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 283 @ $10.71 · Sale (S): 130 @ $10.38 | EDGAR |
| 2024-02-07 | 4 | Verastem, Inc. (VSTM) | Sale (S): 9,204 @ $13.70 | EDGAR |
| 2024-01-17 | 4 | Verastem, Inc. (VSTM) | Sale (S): 9,204 @ $10.95 | EDGAR |
| 2024-01-10 | 4 | Bone Biologics Corp (BBLG) | Grant/award (A): 9 (derivative) @ $0 · Grant/award (A): 8.01 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1504983 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →